Compared to patients with granulomas, cases with increased cytokeratin 19 (31.1% vs 21.0%) and CEA (17.5% vs 4.5%) were all more common in patients with PLCs (each p < 0.05). This evidence concerns the gene CEACAM5 and Granuloma.